Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Athersys Inc
(NQ:
ATHX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Oct 17, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Athersys Inc
< Previous
1
2
3
Next >
Athersys to Host a Virtual Presentation on Its MultiStem® Programs
January 26, 2022
From
Athersys, Inc.
Via
Business Wire
Athersys Appoints Experienced Commercial Leader, Daniel A. Camardo, to Chief Executive Officer
January 20, 2022
From
Athersys, Inc.
Via
Business Wire
Athersys Reports Third Quarter 2021 Results and Provides Corporate Update
November 15, 2021
From
Athersys, Inc.
Via
Business Wire
Alzheimer’s Disease Expected to Triple by 2050 While the Development Process for Potential Drug Candidates Increases
January 05, 2022
Palm Beach, FL – January 5, 2022 – FinancialNewsMedia.com News Commentary – Alzheimer’s disease (AD) is the most common reason of progressive dementia in the elderly population. There has been an...
Via
FinancialNewsMedia
Topics
Death
Exposures
Death
Athersys Reports Updates on Timing for Japan ARDS and Stroke Programs From Healios K.K.
November 12, 2021
From
Athersys
Via
Business Wire
Report of Placebo-Controlled Clinical Trial Evaluating MultiStem® Cell Therapy for Acute Respiratory Distress Syndrome Published in Intensive Care Medicine
November 30, 2021
From
Athersys, Inc.
Via
Business Wire
Athersys to Host Third Quarter Financial Results Call
October 18, 2021
From
Athersys, Inc.
Via
Business Wire
Athersys to Present at 2021 Cell & Gene Meeting on the Mesa Hybrid Conference
September 28, 2021
From
Athersys, Inc.
Via
Business Wire
How Aging-Related Conditions Are Increasing The Treatment Burden For Older Patients
August 13, 2021
Via
FinancialNewsMedia
Athersys Partner HEALIOS K.K. Completes Enrollment in the TREASURE Study of MultiStem Treatment for Ischemic Stroke
August 10, 2021
From
Athersys, Inc.
Via
Business Wire
Athersys Reports Second Quarter 2021 Results
August 09, 2021
From
Athersys, Inc.
Via
Business Wire
Athersys Partner HEALIOS K.K. Announces Positive Topline Results of MultiStem for Acute Respiratory Distress Syndrome in the ONE-BRIDGE Study
August 06, 2021
From
Athersys, Inc.
Via
Business Wire
Athersys and HEALIOS K.K. Announce Advancement of Their MultiStem Commercial Partnership
August 05, 2021
From
Athersys, Inc. and HEALIOS K.K.
Via
Business Wire
Athersys to Host Second Quarter Financial Results Call
July 13, 2021
From
Athersys, Inc.
Via
Business Wire
New Publication Provides Further Clarity of MultiStem's Mechanism of Action on Modulating the Inflammatory Response in Critical Care Indications
June 30, 2021
From
Athersys, Inc.
Via
Business Wire
Athersys Reports First Quarter 2021 Results
May 06, 2021
From
Athersys, Inc.
Via
Business Wire
Athersys to Present at the Bank of America Virtual Healthcare Conference on May 12
April 28, 2021
From
Athersys Inc.
Via
Business Wire
Athersys to Host First Quarter Financial Results Call
April 13, 2021
From
Athersys, Inc.
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.